Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(Z)-Endoxifen supplementation in tamoxifen-treated breast cancer
NCT03931928Phase 2Completed
- Start
- Sep 2019
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of z-endoxifen in breast cancer and ductal carcinoma in situ (DCIS). Started Sep 2019; status: completed.
02
Drugs
z-endoxifen
03
Conditions
breast cancerductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT03931928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03931928.